These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21656767)

  • 1. Phase behavior of TPGS-PEG400/1450 systems and their application to liquid formulation: a formulation platform approach.
    Li J; Yang B; Levons J; Pinnamaneni S; Raghavan K
    J Pharm Sci; 2011 Nov; 100(11):4907-21. PubMed ID: 21656767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel powder formulations for controlled delivery of poorly soluble anticancer drug: application and investigation of TPGS and PEG in spray-dried particulate system.
    Mu L; Teo MM; Ning HZ; Tan CS; Feng SS
    J Control Release; 2005 Apr; 103(3):565-75. PubMed ID: 15820404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs.
    Ke WT; Lin SY; Ho HO; Sheu MT
    J Control Release; 2005 Feb; 102(2):489-507. PubMed ID: 15653166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free flowing solid dispersions of the anti-HIV drug UC 781 with Poloxamer 407 and a maximum amount of TPGS 1000: investigating the relationship between physicochemical characteristics and dissolution behaviour.
    Goddeeris C; Van den Mooter G
    Eur J Pharm Sci; 2008 Sep; 35(1-2):104-13. PubMed ID: 18644442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tocopheryl polyethylene glycol succinate on the percutaneous penetration of minoxidil from water/ethanol/polyethylene glycol 400 solutions.
    Sheu MT; Wu AB; Lin KP; Shen CH; Ho HO
    Drug Dev Ind Pharm; 2006 Jun; 32(5):595-607. PubMed ID: 16720414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tabletability assessment of conventional formulations containing Vitamin E tocopheryl polyethylene glycol succinate.
    Jin F; Tatavarti A
    Int J Pharm; 2010 Apr; 389(1-2):58-65. PubMed ID: 20083178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous effects of tocopheryl polyethylene glycol succinate (TPGS) on local hair growth promotion and systemic absorption of topically applied minoxidil in a mouse model.
    Chen CH; Sheu MT; Wu AB; Lin KP; Ho HO
    Int J Pharm; 2005 Dec; 306(1-2):91-8. PubMed ID: 16253450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The applications of Vitamin E TPGS in drug delivery.
    Guo Y; Luo J; Tan S; Otieno BO; Zhang Z
    Eur J Pharm Sci; 2013 May; 49(2):175-86. PubMed ID: 23485439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential use of cholecalciferol polyethylene glycol succinate as a novel pharmaceutical additive.
    Zhao HZ; Tan EC; Yung LY
    J Biomed Mater Res A; 2008 Mar; 84(4):954-64. PubMed ID: 17647225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier.
    Gan CW; Feng SS
    Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery.
    Lee SH; Zhang Z; Feng SS
    Biomaterials; 2007 Apr; 28(11):2041-50. PubMed ID: 17250886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus.
    Altamimi MA; Neau SH
    Drug Dev Ind Pharm; 2016 Mar; 42(3):446-455. PubMed ID: 26266965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical and dissolution characterization of cilostazol solid dispersions prepared by hot melt granulation (HMG) and thermal adhesion granulation (TAG) methods.
    Chen YC; Ho HO; Chiou JD; Sheu MT
    Int J Pharm; 2014 Oct; 473(1-2):458-68. PubMed ID: 25089508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine.
    Johnson BM; Charman WN; Porter CJ
    AAPS PharmSci; 2002; 4(4):E40. PubMed ID: 12646011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of vitamin E TPGS on the properties of hydrophilic films produced by hot-melt extrusion.
    Repka MA; McGinity JW
    Int J Pharm; 2000 Jul; 202(1-2):63-70. PubMed ID: 10915927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication of D-α-tocopheryl polyethylene glycol 1000 succinates and human serum albumin conjugated chitosan nanoparticles of bosutinib for colon targeting application; in vitro-in vivo investigation.
    Manthalkar L; Bhattacharya S; Hatware K; Sreelaya P; Shah D; Jain A; Phatak N
    Int J Biol Macromol; 2023 Dec; 253(Pt 7):127531. PubMed ID: 37858658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing Mixing Quality of a Copovidone-TPGS Hot Melt Extrusion Process with Atomic Force Microscopy and Differential Scanning Calorimetry.
    Lamm MS; DiNunzio J; Khawaja NN; Crocker LS; Pecora A
    AAPS PharmSciTech; 2016 Feb; 17(1):89-98. PubMed ID: 26283196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
    Zhang Z; Feng SS
    Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Extrusion Spheronization Approach to Enable a High Drug Load Formulation of a Poorly Soluble Drug with a Low Melting Surfactant.
    Tatavarti A; Kesisoglou F
    J Pharm Sci; 2015 Nov; 104(11):3752-3759. PubMed ID: 26205160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing challenges with solid dosage formulations containing vitamin E TPGS.
    Pandey P; Sinko PD; Bindra DS; Hamey R; Gour S; Vema-Varapu C
    Pharm Dev Technol; 2013 Feb; 18(1):296-304. PubMed ID: 23136832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.